Amlodipin Interpharm

Quick links to important sections

Amlodipin Interpharm

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amlodipin Interpharm

Quick Facts

Property Description
Active ingredient Amlodipine (as besilate salt)
Form Oral Tablet
Pharmacological class Calcium Channel Blocker (CCB)
Common purpose To manage blood pressure and support heart function
Origin Synthetic (Dihydropyridine derivative)

What Type of Medicine is Amlodipin Interpharm?

Amlodipin Interpharm is a synthetic, single-ingredient cardiovascular medication containing the active substance Amlodipine (INN). It is officially classified as a Calcium Channel Blocker (CCB), belonging specifically to the dihydropyridine subclass. This medicine is an antihypertensive agent used in long-term maintenance therapy. Amlodipin Interpharm is typically dispensed as a prescription-only medicine (POM), positioning it for supervised management of chronic conditions such as high blood pressure in adult and geriatric patient groups.

Composition and Pharmaceutical Form of Amlodipine

The medicine is supplied as an oral dosage form, typically a film-coated tablet, intended for systemic absorption after ingestion. The active compound is often formulated as the stable salt, Amlodipine besilate. As a single-entity product manufactured under the brand Interpharm, its composition includes the active substance and necessary solid pharmaceutical excipients (such as fillers and binders) required to create a consistent, durable structure suitable for reliable oral administration. This formulation ensures stable, measured delivery of the drug for a consistent therapeutic effect.

General Purpose and Action Principle

The general purpose of this medication is to support heart and circulatory health by helping to regulate and lower blood pressure. It achieves its effect by selectively blocking the entry of calcium ions into the cells of the blood vessel walls. This action prevents the sustained contraction of vascular smooth muscle, causing the blood vessels to relax and widen (vasodilation). This mechanism reduces peripheral vascular resistance and eases the heart's workload. This core function contributes to the long-term optimization of cardiovascular function in patients with chronic circulatory challenges.

Regulatory References

  1. NIH DailyMed label for Amlodipine
  2. National Institute for Health and Care Excellence (NICE)

What side effects are possible with Amlodipin Interpharm?

Possible Side Effects and Safety Information

The official safety profile for amlodipine, the active ingredient in Amlodipin Interpharm, is derived from regulatory documents, classifying adverse reactions by frequency and the body system affected.

Frequency-Classified Adverse Reactions

The most commonly documented effects are related to the drug's vasodilatory action.

Frequency Example Adverse Reactions
Very Common (≥1/10) Oedema (swelling)
Common (≥1/100 to <1/10) Headache, Somnolence, Dizziness, Palpitations, Flushing, Nausea, Abdominal pain, Fatigue, Ankle swelling.
Uncommon (≥1/1,000 to <1/100) Insomnia, Mood changes, Tremor, Syncope, Hypotension, Vomiting, Rash, Pruritus, Joint pain (Arthralgia), Muscle pain (Myalgia), Impotence, Gynaecomastia.
Rare/Very Rare (<1/1,000) Myocardial infarction (heart attack), Arrhythmia, Hepatitis, Pancreatitis, Gingival hyperplasia, Angioedema, Stevens-Johnson syndrome, Exfoliative dermatitis.

Serious Adverse Reactions and Restrictions

Serious Adverse Reactions documented in official sources include myocardial infarction, certain arrhythmias, and severe cutaneous adverse reactions like Stevens-Johnson syndrome. These events are classified as very rare.

Safety Restrictions (Contraindications): The medicine is strictly contraindicated in cases of severe hypotension (low blood pressure), cardiogenic shock, and known hypersensitivity to the substance or other dihydropyridines.

Population Safety Considerations: Caution is advised when used in patients with hepatic impairment (liver problems) due to reduced drug clearance. A lower initial dose may be necessary. Caution is also required in patients with severe heart failure (NYHA Class III and IV) due to a reported risk of pulmonary oedema.

Dose- or Duration-Related Patterns: The most common effect, oedema, is explicitly noted as being dose-related in regulatory labeling. Headache and dizziness are often reported to occur especially at the beginning of treatment.

Overdose and Emergency Response

Overdose and when to seek help

This section reflects information on Amlodipin Interpharm overdose strictly as documented in official government regulatory documents.

Overdose Entity Official Regulatory Documentation Statement
Documented overdose presentations Excessive peripheral vasodilation leading to marked and probably prolonged systemic hypotension. Massive over-ingestion may result in reflex tachycardia or, in severe cases, bradycardia and reduced cardiac output.
Dose-related or exposure-related factors Overdose carries a risk of refractory shock, for which fatal outcome has been reported.
Emergency-response statements Initiate active cardiac and respiratory monitoring immediately; frequent blood pressure measurements are essential.
When immediate medical help is required Urgent professional medical assistance is required if severe systemic hypotension or the clinical state of shock is present or suspected.

Official overdose statements:

  • No specific efficacious antidote is known for Amlodipine overdose, and hemodialysis is not likely to be of benefit.
  • Management focuses on immediate cardiovascular support, including elevation of the extremities and judicious administration of fluids.
  • The use of vasopressors (such as phenylephrine), intravenous calcium salts, and glucagon are documented supportive management procedures for refractory hypotension.

Connection to the overall overdose profile: Regulatory documents define the overdose profile by focusing on the resulting severe hemodynamic instability that requires immediate medical attention and continuous active monitoring. The official guidance establishes that management relies entirely on aggressive symptomatic and supportive treatment to stabilize cardiovascular function due to the lack of a known specific antidote.

Therapeutic Uses of Amlodipin Interpharm

What Amlodipin Interpharm Treats: Main Uses and Benefits

Amlodipine Interpharm is commonly used to help with patients managing symptoms related to systemic imbalance and organ-specific functional stress. The medication plays a role in managing chronic conditions such as Systemic Arterial Hypertension (high blood pressure), Chronic Stable Angina, Vasospastic Angina, and established Coronary Artery Disease (CAD).

In clinical scenarios, it is relevant when supportive symptom management is appropriate for long-term care. The medication supports the reduction of persistent pressure and is relevant for easing episodic chest discomfort. This contributes to easing the overall symptom load. It may assist with supporting the reduction of long-term risk of severe cardiovascular complications.

“This approach assists with maintaining functional stability and supports the patient during difficult episodes by easing distress.”

Quick Fact: Supports Management of Cardiovascular Strain
Therapeutic Role Management of chronic high blood pressure and angina pain
Symptom Focus Systemic imbalance and recurrent chest discomfort
Main Benefit Supports reduction of long-term risk and eases symptom burden

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Amlodipin Interpharm? (Official Regulatory Information)

Official regulatory documents define specific populations who are permitted, restricted, or prohibited from using Amlodipin Interpharm (Amlodipine).

Eligibility Restrictions and Exclusions

Restriction Category Population or Condition
Absolute Contraindication Patients with known hypersensitivity to amlodipine or other dihydropyridine derivatives.
Absolute Contraindication Patients in shock, with severe hypotension, or haemodynamically unstable heart failure after a heart attack.
Conditional Use Patients with hepatic impairment (liver function problems) require caution and may need a lower starting dose.
Not Recommended Children under 6 years of age (use for hypertension is not established).
Not Recommended Breastfeeding mothers, as the medicine is excreted into human milk.

Approved and Restricted Age Groups

Use is established in adults for approved indications. Eligibility is extended to children aged 6 to 17 years specifically for the treatment of Hypertension. For older adults, the official prescribing information advises caution and consideration of a lower initial dose.

What should I know about interactions with other medicines?

Amlodipin Interpharm (amlodipine) can interact with a range of other medicines, potentially altering its effects or increasing the risk of side effects. It is crucial to inform your doctor about all prescription and over-the-counter medicines, supplements, and herbal products you are currently taking.

Medicines that can Increase Amlodipine Effects

Co-administration with certain drugs can increase the concentration of amlodipine in the body, which may lead to an increased risk of side effects like very low blood pressure (hypotension) or swelling (edema). These include:

  • Certain antibiotics: such as clarithromycin or erythromycin.
  • Certain antifungals: such as itraconazole or ketoconazole.
  • Certain HIV/HCV protease inhibitors: such as ritonavir or cobicistat.
  • Other calcium channel blockers: such as diltiazem.

Medicines that can Decrease Amlodipine Effects

Some medicines can accelerate the breakdown of amlodipine in the body, potentially reducing its effectiveness in lowering blood pressure. These include:

  • Certain anti-epilepsy medicines: such as phenytoin, carbamazepine, or phenobarbital.
  • Rifampicin (an antibiotic).
  • St. John's wort (a herbal supplement).

️ Other Important Interactions

Interacting Product Potential Effect
**Simvastatin** (for high cholesterol) Amlodipine can increase simvastatin levels; the dose of simvastatin may need to be limited.
**Immunosuppressants** (e.g., ciclosporin, tacrolimus) Amlodipine can increase the concentration of the immunosuppressant, requiring close monitoring.
**Other blood pressure lowering medicines** May cause an additive effect, leading to excessive blood pressure reduction.
**Grapefruit or Grapefruit Juice** Should be avoided as they may increase amlodipine effects.

Your healthcare provider may need to adjust the dosage of Amlodipin Interpharm or the interacting medication, or monitor you more closely.

Mechanism of Action

Blocking Calcium Influx in Vascular Cells

Amlodipin Interpharm acts as a specific inhibitor of the L-type voltage-dependent calcium channel (Cav1.2). This target is primarily expressed on the surface of vascular smooth muscle cells (VSMCs) in the systemic and coronary arteries. The binding action blocks the necessary influx of extracellular calcium ions (Ca^2+), which are required as the molecular signal to initiate the contraction of these muscle cells.


Relaxing Blood Vessels and Reducing Resistance

By inhibiting Ca^2+ entry, the drug modulates the contractile state of the VSMCs by interfering with the activation of the myosin light-chain kinase. This mechanism leads to the muscle cells' relaxation, a process known as vasodilation. This physiological change primarily targets the peripheral arterioles and coronary arteries, resulting in a reduction in the overall peripheral vascular resistance (afterload).


Resulting Systemic Physiological Change

The systematic reduction in resistance against which the heart must pump is the core outcome of the drug’s mechanism. This key change in the body's vascular tone directly leads to a decrease in arterial blood pressure, which results from the modulation of systemic circulatory pathways.

Dosage and Administration Information

How to Use Amlodipin Interpharm: Official Administration Guidelines

Amlodipin Interpharm is structured for long-term, chronic administration through the oral route as a tablet. The administration schedule is strictly once daily, and the medicine should be ingested at approximately the same time each day to maintain consistent blood levels. The tablets may be taken with or without food and should be swallowed whole with water.


Standard Dosing Regimens and Adjustments

Official guidelines define specific dose ranges based on patient population and response. For most adults, the usual initial starting dose is 5 mg once daily. Doses are typically adjusted by a healthcare professional after a period of 7 to 14 days, with the maximum recommended daily dose being 10 mg.


Population-Specific Instructions

Population Starting Dose Guideline Maximum Daily Dose
Adults (Hypertension/Angina) 5 mg once daily 10 mg
Pediatric (6–17 years, Hypertension) 2.5 mg once daily 5 mg
Older Adults / Hepatic Impairment 2.5 mg once daily is commonly considered 10 mg

If a dose is missed, it should be taken as soon as the omission is noted, unless the next scheduled dose is approaching. If the time for the next dose is near, the missed dose is skipped, and the regular schedule is resumed; a double dose is not to be administered.


The instructions for use define a standardized, once-daily protocol for administration, establishing the limits for the initial dose, the process for titration, and the maximum dosage across different patient groups, ensuring adherence to the standard for use.

Recent Clinical Evidence

Amlodipin Interpharm: Recent Clinical Evidence

Clinical research involving amlodipine, the active ingredient in Amlodipin Interpharm, has consistently focused on its use in managing hypertension (high blood pressure) and chronic stable angina (chest pain).

Efficacy in Core Indications

Large-scale randomized controlled trials (RCTs) confirm the role of amlodipine as a long-acting calcium channel blocker. Studies have demonstrated its capacity to lower blood pressure, which is maintained over a 24-hour period, supporting once-daily dosing. In patients with stable angina, research indicates that amlodipine is associated with an increase in exercise time and a reduction in both the frequency of anginal attacks and the need for nitroglycerin use.

Cardiovascular Outcome Data

Major comparative trials have investigated the effect of amlodipine on long-term cardiovascular outcomes. These studies suggest that the compound is comparable to certain other first-line antihypertensive agents in reducing the incidence of major cardiovascular events, such as non-fatal myocardial infarction (heart attack) and stroke. A recent meta-analysis also addressed past concerns, concluding that amlodipine use is not associated with an increased risk of heart failure or other related cardiovascular problems.

Safety Profile and Tolerability

Clinical data show that the medication is generally well tolerated, with most reported side effects being mild to moderate in severity. The most commonly reported adverse event in trials is peripheral edema (swelling of the ankles or feet). Other frequent, though less common, events include headache, dizziness, and flushing. These events are often dose-dependent and may improve with time or dose adjustment. No major dose modifications are typically required for patients with renal impairment.

Frequently Asked Questions (FAQ)

Common questions about Amlodipin Interpharm (FAQ)

Q: What is Amlodipin Interpharm used for?

Amlodipin Interpharm is a medicine used to treat high blood pressure (hypertension) and chest pain caused by reduced blood flow to the heart (angina pectoris). It belongs to a group of medicines called calcium channel blockers.


Q: How does Amlodipin Interpharm work in the body?

Amlodipin works by relaxing the blood vessels, which allows blood to flow more easily. This makes it easier for the heart to pump blood around the body and also helps to increase the blood supply to the heart muscle, thereby treating angina.


Q: When is the best time to take Amlodipin Interpharm?

It is generally recommended to take Amlodipin Interpharm at the same time each day, either in the morning or in the evening. It can be taken with or without food. The key is consistency to maintain a stable level of the medicine in your body.


Q: What should I do if I miss a dose of Amlodipin Interpharm?

  • If you forget to take your dose, take it as soon as you remember.
  • However, if it is almost time for your next dose (e.g., within 12 hours of the next scheduled dose), skip the missed dose and continue with your regular dosing schedule.
  • Do not take a double dose to make up for a forgotten dose.

Q: Are there any foods or drinks I should avoid while taking Amlodipin Interpharm?

Grapefruit and grapefruit juice should be avoided while taking this medicine. They can increase the amount of amlodipine in your blood, potentially leading to an unwanted drop in blood pressure. Discuss any concerns about diet or alcohol consumption with your doctor or pharmacist.


Q: What are some common side effects of Amlodipin Interpharm?

Like all medicines, Amlodipin Interpharm can cause side effects, although not everyone gets them. Some common side effects include:

  • Headache
  • Dizziness
  • Swelling (oedema), particularly of the ankles and feet
  • Flushing (redness and warmth of the skin)
  • Fatigue or extreme tiredness

If you experience any bothersome side effects, discuss them with your doctor.

How should Amlodipin Interpharm be stored and disposed of?

How to Store and Dispose of Amlodipin Interpharm

Storage and disposal must strictly adhere to regulatory requirements to ensure product integrity and safety.

Storage Requirements

Amlodipine tablets must be stored at controlled room temperature, maintaining a range between 20 C to 25 C (68 F to 77 F). The medication must be protected from light and kept in a dry place. This requires that the product should not be stored in high-humidity areas, such as a bathroom, and must be retained in the original container.

Handling and Child Safety

As required by regulatory labeling, the medicine must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Amlodipine must not be disposed of via wastewater or household waste. Disposal must follow local requirements, typically by returning the medication to a pharmacy or designated collection point for safe pharmaceutical waste handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amlodipin Interpharm found in:

A-Z Index: